Learn More
PURPOSE Long-term brain metastases survivors are at risk for neurologic morbidity after whole-brain radiotherapy (WBRT). Retrospective radiosurgery (RS) reports found no survival difference when(More)
8589 Background: RTOG 0118 was a randomized trial of WBRT (37.5 Gy/15 fractions) ± thalidomide in patients (pts) with brain metastases, which showed no effect on survival (Knisely et al, ASCO, 2005).(More)
1507 Background: Whole brain radiation therapy (WBRT) is considered standard therapy for patients (pts.) w/ brain metastasis. Long term survivors are at risk for CNS morbidity, and the value of low(More)